Ozempic is driving up the cost of your health care, whether you can get your hands on it or not

[ad_1] About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get…

Stocks making the biggest moves midday: Wynn Resorts, Rocket Lab USA, Cassava Sciences and more

[ad_1] Check out the companies making headlines in midday trading: Bristol-Myers Squibb — The drug maker…

Novo Nordisk’s diabetes drug Ozempic may lower the risk of opioid overdoses, study says

[ad_1] A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London,…

Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next

[ad_1] Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy in…

‘Stop ripping us off’: Novo Nordisk CEO faces Senate grilling over weight loss drug prices

[ad_1] Novo Nordisk‘s top executive faces a Senate grilling on Tuesday over the high prices of…

FTC sues drug middlemen for allegedly inflating insulin prices

[ad_1] Lina Khan, Chair of the Federal Trade Commission (FTC), testifies before the House Appropriations Subcommittee…

Why Eli Lilly and Palo Alto Networks are both up on news from their competitors

[ad_1] Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable…

Novartis not joining the ‘frenzy’ of weight loss drugs, CEO says

[ad_1] The CEO of Novartis said Wednesday that the Swiss pharmaceutical giant does not plan to…

Healthy Returns: How competitive can Roche be in the weight loss drug market?

[ad_1] Headquarters of Roche, multinational pharmaceutical industry on December 27, 2021 in Madrid, Spain.  Cristina Arias…

Eli Lilly says it will invest $1.8 billion to expand manufacturing for weight loss, diabetes and Alzheimer’s drugs

[ad_1] A sign with the company logo sits outside of the headquarters of Eli Lilly in…

Healthy Returns: More than 50 million privately insured adults could be eligible for GLP-1 drugs

[ad_1] Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der…

Healthy Returns: Eli Lilly could soon become the first $1 trillion health-care stock

[ad_1] A sign with the company logo outside the headquarters of Eli Lilly and Company in…

Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply

[ad_1] Eli Lilly on Tuesday released a new form of its weight loss drug Zepbound for…

Health-care marketplace Sesame to offer compounded versions of Wegovy through new $249 weight loss program

[ad_1] Health-care marketplace Sesame on Wednesday announced a new clinical weight loss program that will help…

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

[ad_1] Eli Lilly’s highly popular weight loss drug reduced the risk of developing Type 2 diabetes…